SALT LAKE CITY, Aug. 31, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary supplement, announced today it will release financial results for its fourth fiscal quarter and full year ended June 30, 2012, after the market closes on Monday, September 10, 2012. The Company will hold an investor conference call at 2:30 p.m. Mountain Daylight Time (4:30 p.m. Eastern Daylight Time).
Investors interested in participating in the live call can dial (888) 587-0613 from the U.S. International callers can dial (719) 457-2710. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, September 12, 2012, by dialing (877) 870-5176 from the U.S., or (858) 384-5517 from international locations, and entering confirmation code 8430189.
There also will be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at http://investor.lifevantage.com/events.cfm . The webcast will be archived for 30 days.To receive email alerts regarding LifeVantage's upcoming investor events, stock information, SEC filings, or Company issued press releases, please visit the Company's investor relations page and sign up for Email Subscription Alerts: http://investor.lifevantage.com/alerts.cfm . About LifeVantage Corporation LifeVantage, (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary supplement, is a science based nutraceutical company. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2004 and is headquartered in Salt Lake City, UT. The LifeVantage Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=11617
CONTACT: Investor Relations Contact: Cindy England (801) 432-9036 Director of Investor Relations -or- John Mills (310) 954-1105 Senior Managing Director, ICR, LLC